The Kaposi’s Sarcoma-Associated Herpesvirus (KSHV) gH/gL Complex Is the Predominant Neutralizing Antigenic Determinant in KSHV-Infected Individuals
Kaposi’s sarcoma-associated herpesvirus (KSHV) is the etiological agent of Kaposi’s sarcoma (KS), one of the most prevalent cancers of people living with HIV/AIDS in sub-Saharan Africa. The seroprevalence for KSHV is high in the region, and no prophylactic vaccine against the vir...
Main Authors: | Yasaman Mortazavi, Salum J. Lidenge, Tara Tran, John T. West, Charles Wood, For Yue Tso |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-02-01
|
Series: | Viruses |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4915/12/3/256 |
Similar Items
-
Antibodies Targeting KSHV gH/gL Reveal Distinct Neutralization Mechanisms
by: Thomas Fricke, et al.
Published: (2022-03-01) -
Well Put Together—A Guide to Accessorizing with the Herpesvirus gH/gL Complexes
by: Gonzalo L. Gonzalez-Del Pino, et al.
Published: (2022-01-01) -
Treatment of Kaposi sarcoma-associated herpesvirus (KSHV)-associated cancers
by: Dirk P Dittmer, et al.
Published: (2012-04-01) -
Kaposi's sarcoma associated herpesvirus (KSHV) entry into target cells
by: Sayan eChakraborty, et al.
Published: (2012-01-01) -
Suppression of DC-SIGN and gH Reveals Complex, Subset-Specific Mechanisms for KSHV Entry in Primary B Lymphocytes
by: Nancy Palmerin, et al.
Published: (2021-07-01)